Increased incidence of cytoplasmic ANCA (cANCA) and other autoantibodies in leprosy patients from Western India

Leprosy Review

Volumn 75, Issue 1, 2004, Pages 50-56

  Pradhan, Vandana ^a   Badakere, S S ^a   Kumar, U Shankar ^a  

^a KEM HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; DNA ANTIBODY; DOUBLE STRANDED DNA; HISTONE ANTIBODY; LACTOFERRIN; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; RHEUMATOID FACTOR; RIBONUCLEOPROTEIN ANTIBODY; SCL 70 ANTIBODY; SINGLE STRANDED DNA; SM ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INDIA; LEPROMATOUS LEPROSY; LEPROSY; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM LEPRAE; SEX DIFFERENCE; TUBERCULOID LEPROSY;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INCIDENCE; INDIA; LEPROSY; LEPROSY, BORDERLINE; LEPROSY, LEPROMATOUS; LEPROSY, TUBERCULOID; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 1642368772     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ridley DS. Jopling WH. Classification of leprosy according to immunity, a five group system. Int J Lepr, 1996; 34: 255-273.
2. Rawlinson WD, Basten A, Haryrare JC. Clinical significance of changes in serum proteins, immunoglobulins, and autoantibodies in leprosy. Int J Lepr, 1987; 55: 277-285.
3. Furukawa F, Kashihara M, Imamura S et al. Evaluation of anti-cardiolipin antibody and its cross reactivity in sera of patients with lepromatous leprosy. Arch Dermatol, 1986; 278: 317-319.
4. Mackworth-Young C, Sabbha G, Schwartz RS. Idiotypic markers of polyclonal B cell activation. J Clin Invest, 1987; 79: 572-581.
5. Rapoport BL, Morrison RCA, Sher R, Dos Santos L. A study of autoantibodies in chronic mycobacterial infections. Int J Lepr, 1990; 58: 518-525.
6. Garcia-DE La Torre I. Autoimmune phenomena in leprosy, particularly anti-nuclear antibodies and rheumatoid factor. J Rheumatol, 1993; 20: 900-903.
7. Guedes Barbosa LS, Gilbrut B, Shoenfeld Y, Scheinberg MA. Autoantibodies in leprosy sera. Clin Rheum, 1996; 15: 26-28
8. Badakere SS, Chablani A, Bhatia H et al. Anti-nuclear factor in some autoimmune disorders' Proc Recent Trends Immun Haematol, 1982; 101.
9. Badakere S, Chablani A. Immunofluorescent techniques in immunohaematology. Immunohaematol Bull, 1985; 16: 1.
10. Badakere S, Chablani A. Significance of antibodies to ENA (Sm+RNP) and patterns of immunofluorescence in the diagnosis of some collagen vascular autoimmune disorders. Ind J Haematol Blood Transf, 1994; 12: 107.
11. Hatfield M, Evans M, Suenaga R et al. Anti-idiotypic antibody against anti-DNA in sera of laboratory personnel exposed to lupus sera or nucleic acids. Clin Exp Immunol, 1987; 70: 26-34.
12. Krippner H, Springer B, Merle S, Pirle K. Antibodies to histone of the IgG and IgM class in systemic lupus erythematosus. Clin Exp Immunol, 1984; 58: 49.
13. Savige J, Davies D, Falk R et al. Anti-neutrophil cytoplasmic antibodies and assiciated diseases; a review of the clinical and laboratory features. Kidney Int, 2000; 57: 846-862.
14. Badakere SS, Pradhan VD. ANCA: anti-neutrophil antibodies and their role in vasculitis associatead kidney disorders. Ind J Med Sci, 2002; 56: 335-359.
15. Esnault VLM, Short AK, Audrain MAP et al. Autoantibodies to lactoferrin and histone in systemic vasculitis identified by anti-myeloperoxidase solid phase assays. Kidney Int, 1994; 46: 153-160.
16. Rasmusen N, Sjolin C, Isaksson B et al. An ELISA for the detection of anti-neutrophil cytoplasm antibodies (ANCA). J Immunol Meth, 1990; 127: 139-145.
17. Pradhan VD, Badakere SS, Shankar Kumar U et al. Anti-neutrophil cytoplasmic antibodies (ANCA) in Malaria. Ind J Hematol Blood Trans 2002; 20: 24.
18. Kroumpouzos G, Vareltzidis A, Konstadoulakes MM et al. Evaluation of the autoimmune response in leprosy. Lepr Rev, 1993; 64: 199-207.
19. Miller RA, Wener MH, Harnisch JP, Gilliland BC. The limited spectrum of anti-nuclear antibodies in leprosy. J Rheumatol, 1987; 14: 108-110.
20. Bonfa E, Llovert R, Scheinberg M et al. Comparison between autoantibodies in malaria and leprosy with lupus Clin Exp Immunol, 1987; 70: 529-537.
21. Cossermelli MW, Cossermelli W. Humoral immunity in Hansen's disease. Rev Paul Med, 1995; 113: 929-934.
22. MacAdam KPWJ, Mudd D, Shoenfeld Y et al. Autoantibodies to DNA in leprosy: antigenic similarities between DNA and mycobacterial phospholipids defined by human monoclonal antibodies. Int J Lepr, 1984; 52: 697.
23. Chogle AR. Rheumatic manifestations of leprosy. JAPI, 1999; 47: 573-575.
24. Petchclai B, Chuthanondh R, Rungruong S, Ramasoota T. Autoantibodies in leprosy among Thai patients. Lancet, 1973; 1481-1483.
25. Medina F, Camargo A, Moreno J et al. Anti-neutrophil cytoplasmic antibodies in leprosy. Br J Rheumatol, 1998; 37: 270-273.
26. Charles JA, Falk R, Jennette J. Acitivity of anti-neutrophil cytoplasmic antibodies with HL-60 cells. J Immunol Immunopathol, 1989; 53: 243-253.
27. Freire BF, Ferraz AA, Nakayama E et al. Anti-neutrophil cytoplasmic antibodies (ANCA) in the clinical forms of leprosy. Int J Lepr, 1998; 66: 472-482.
28. Luqmani RA, Bacon PA, Beaman M et al. Classical verses non-renal Wegener's granulomatosis. Q J Med, 1994; 87: 161-167.